- Home
- Mathematics
- Probability & Statistics
- Precision Medicine and Companion Diagnostic Devices
Precision Medicine and Companion Diagnostic Devices
List Price:
$99.95
| Expected release date is Dec 31st 2030 |
- Availability: Confirm prior to ordering
- Branding: minimum 50 pieces (add’l costs below)
- Check Freight Rates (branded products only)
Branding Options (v), Availability & Lead Times
- 1-Color Imprint: $2.00 ea.
- Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
- Belly-Band Wrap: $2.50 ea. (full-color printed)
- Set-Up Charge: $45 per decoration
- Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
- Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
- Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
- RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
Product Details
Author:
Meijuan Li
Format:
Hardcover
Pages:
250
Publisher:
CRC Press (December 31, 2030)
Release Date:
December 31, 2030
Language:
English
Audience:
Professional and scholarly
ISBN-13:
9781138033634
Weight:
16oz
Dimensions:
7" x 10"
File:
TAYLORFRANCIS-TayFran_250815043118849-20250815.xml
Folder:
TAYLORFRANCIS
List Price:
$99.95
Series:
Chapman & Hall/CRC Biostatistics Series
Case Pack:
1
As low as:
$94.95
Publisher Identifier:
P-CRC
Discount Code:
H
Pub Discount:
30
Country of Origin:
United States
Imprint:
Chapman and Hall/CRC
Overview
A key component of personalized medicine is companion diagnostics that measure biomarkers e.g. protein expression, gene amplification or specific mutations. This will be the first book that covers (1) companion diagnostic device measurement performance, (2) companion diagnostic device clinical performance, (3) companion diagnostic device bridging study, (4) follow-on companion diagnostic device, and (5) the impact of companion diagnostic device measurement performance on clinical validation of personalized medicine.
